Loading...
BVMF
BALM3
Market cap26mUSD
May 12, Last price  
16.30BRL
Name

Baumer SA

Chart & Performance

D1W1MN
P/E
5.54
P/S
0.83
EPS
2.94
Div Yield, %
—
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
5.42%
Revenues
194m
+14.38%
53,936,00065,106,00065,303,00074,055,00085,202,00094,812,00093,512,00099,746,000108,697,000116,297,000112,044,000113,105,000109,754,000119,803,000149,310,000325,946,000267,640,000329,088,000169,950,000194,386,000
Net income
29m
+227.30%
3,382,0005,421,0001,833,0004,215,0001,980,0003,717,0006,933,0008,458,00013,128,00011,497,00014,352,0003,016,000675,0002,753,0004,194,00016,431,00010,132,0005,709,0008,940,00029,261,000
CFO
31m
+22.21%
578,0003,240,000201,0007,075,0001,503,0008,867,0005,034,0004,694,000766,0005,534,000-2,870,00014,527,00026,325,00017,635,0003,133,00025,593,00031,278,000
Dividend
Dec 06, 20230.77647 BRL/sh

Profile

Baumer S.A. develops solutions in hospitals, odontology, and health industry equipment in Brazil, Europe, Asia, and the United States. It offers sterilization and infection control solutions, such as steam sterilizers, formoldehyde and hydrogen peroxide steam sterilizers, solid waste treatment systems, ethylene oxide sterilizers, thermal washer disinfectors, drying cabinets, ultrasonic reprocessors, preparation and storage systems, loading and water treatment systems, test and control, and steam generators. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables; and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as pedicle fixation system, occipitocervial fixation systems, cervical cage angled, and posterior lumbar cages. Further, the company offers dental solutions, including implants and biomaterials. It serves hospitals, clinics, hemocenters, universities, public health service, and carrier health markets; and pharmaceutical, food, and cosmetics industries, as well as research institutes and laboratories. The company was founded in 1952 and is based in Pacaembu, Brazil.
URL
https://www.baumer.com.br/
IPO date
Jun 06, 1995
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
194,386
14.38%
169,950
-48.36%
329,088
22.96%
Cost of revenue
160,338
146,650
141,728
Unusual Expense (Income)
NOPBT
34,048
23,300
187,360
NOPBT Margin
17.52%
13.71%
56.93%
Operating Taxes
10,207
5,673
3,968
Tax Rate
29.98%
24.35%
2.12%
NOPAT
23,841
17,627
183,392
Net income
29,261
227.30%
8,940
56.59%
5,709
-43.65%
Dividends
(7,484)
(4,796)
Dividend yield
4.90%
Proceeds from repurchase of equity
26
(4,058)
BB yield
-0.02%
4.15%
Debt
Debt current
2,724
3,791
6,673
Long-term debt
14,001
16,340
18,983
Deferred revenue
Other long-term liabilities
2,742
23,477
841
Net debt
(3,542)
(73,374)
13,365
Cash flow
Cash from operating activities
31,278
25,593
3,133
CAPEX
(5,423)
(6,078)
Cash from investing activities
(2,852)
(5,298)
(3,316)
Cash from financing activities
(11,061)
(4,154)
(489)
FCF
14,950
27,182
173,781
Balance
Cash
76,827
59,462
43,320
Long term investments
(56,560)
34,043
(31,029)
Excess cash
10,548
85,008
Stockholders' equity
66,584
145,599
134,590
Invested Capital
183,463
104,370
159,081
ROIC
16.57%
13.38%
118.87%
ROCE
15.88%
12.18%
102.22%
EV
Common stock shares outstanding
9,785
9,785
Price
11.00
-4.51%
11.52
15.20%
10.00
-22.96%
Market cap
112,718
15.20%
97,845
-22.96%
EV
40,703
112,262
EBITDA
39,033
28,168
191,466
EV/EBITDA
1.44
0.59
Interest
8,650
9,564
1,453
Interest/NOPBT
25.41%
41.05%
0.78%